Dr. Lal Pathlabs (LALPATHLAB) Share Price Rises 2.2% to Rs 2,014.15
- October 6, 2026
- Posted by: Kunal Singla
- Category: News
Dr. Lal Pathlabs Share Price is trading higher today at Rs 2,014.15, up 2.2% from the previous close, with market capitalisation at Rs 33,679.7 crore. The move places Dr. Lal Pathlabs Share Price in focus in Healthcare share price news and Dr. Lal Pathlabs Stock News, even though no company-specific catalyst is established. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Dr. Lal Pathlabs Share Price Today, the session shows a clear intraday gain while the broader narrative remains tied to price action, valuation and the company’s operating profile. In Univest analysis, the key questions are straightforward: what changed in the stock, how do the core ratios look, and how does the valuation compare with the healthcare set?
Dr. Lal Pathlabs Share Price is also drawing attention because the stock sits in a sector where market capitalisation, P/E Ratio, P/B Ratio, ROE and ROCE are watched closely. The latest Univest figures suggest that today’s share price gain is meaningful enough to merit a closer look at Dr. Lal Pathlabs Share Price Live, Dr. Lal Pathlabs Share Price Update and Dr. Lal Pathlabs Stock Performance without assuming any cause beyond the verified move.
Dr. Lal Pathlabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,014.15 |
| Previous Close | Rs 1,970.7 |
| Today's Move | Rs 43.45 (+2.2%) |
| Open | Rs 1,995 |
| High | Rs 2,015.6 |
| Low | Rs 1,984.4 |
| Market Capitalisation | Rs 33,679.7 crore |
| Market Cap Category | Large Cap |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) rose to Rs 2,014.15 from the previous close of Rs 1,970.7, a move of Rs 43.45 or 2.2%. The stock opened at Rs 1,995, reached a high of Rs 2,015.6, recorded a low of Rs 1,984.4.
Dr. Lal Pathlabs Share Price moved up by Rs 43.45 from the previous close and was last traded at Rs 2,014.15. The stock opened at Rs 1,995, touched a high of Rs 2,015.6 and a low of Rs 1,984.4, so the day’s movement stayed within a defined intraday band while keeping Dr. Lal Pathlabs Share Price in positive territory.
For Dr. Lal Pathlabs Share Price Today, the arithmetic is simple: the current price is above the previous close, the day change is 2.2%, and the move has pushed the stock into the day’s higher zone. In Dr. Lal Pathlabs Stock News, that makes the price rise the main event, not a broader conclusion. According to latest Univest data, the fact pattern confirms a share price gain, but not a company-specific trigger. Dr. Lal Pathlabs NSE and Dr. Lal Pathlabs BSE investors will therefore read today’s move as a price action event first and a narrative event later. Dr. Lal Pathlabs Share Price remains the central lens here before the discussion shifts to Dr. Lal Pathlabs Fundamental Analysis.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 33,679.7 crore |
| P/E Ratio | 61.04x |
| P/B Ratio | 12.66x |
| ROE | 22.37% |
| ROCE | 29.56% |
| EPS | Rs 32.29 |
| Book Value Per Share | Rs 155.67 |
| Dividend Yield | 1.04% |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) fundamental metrics show P/E 61.04x, P/B 12.66x, ROE 22.37%, ROCE 29.56%. These figures provide context only and are not a buy or sell signal.
Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 33,679.7 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.04x, P/B at 12.66x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.75x, median ROE of 13.01%, median ROCE of 15.84%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 61.04x |
| Benchmark Median P/E | 44.75x |
| Benchmark Average P/E | 97.08x |
| Benchmark P/E Range | 6.78x to 1,588.84x |
| Company P/B Ratio | 12.66x |
| Benchmark Median P/B | 3.92x |
| Company ROE | 22.37% |
| Benchmark Median ROE | 13.01% |
| Company ROCE | 29.56% |
| Benchmark Median ROCE | 15.84% |
| Company Market Capitalisation | Rs 33,679.7 crore |
| Benchmark Median Market Cap | Rs 555.31 crore |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 61.04x, which is above the benchmark median of 44.75x, a difference of +36.4%. On its own, the P/E gap is a valuation reference point, not a trading call.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 13.01%, a difference of +71.94%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.84%, a difference of +86.62%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP | 1,16,695.63 | 55.12 | 11.89 | 23.54 | 21.73 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 91,963.22 | 61.23 | 8.16 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 91,517.37 | 98.37 | 4.81 | 12.95 | 13.93 |
| Aster DM Healthcare Ltd. | ASTERDM | 61,779.78 | 189.01 | 14.24 | 13.07 | 16.22 |
| Fortis Healthcare Ltd. | FORTIS | 59,332.16 | 55.11 | 5.68 | 11.32 | 14.07 |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 61.04x compared with the displayed peer median of 61.23x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 33,679.7 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Dr. Lal Pathlabs
- Dr. Lal Pathlabs Share Price rose 2.2% today, making the stock one of the notable movers in its segment.
- The current price, previous close and intraday range show a clean share price rise without needing a catalyst story.
- Dr. Lal Pathlabs Fundamental Analysis highlights a P/E Ratio of 61.04, P/B Ratio of 12.66 and ROCE of 29.56%.
- The Healthcare sector benchmark shows the company’s P/E, ROE and ROCE above the industry median.
- Peer comparison places Dr. Lal Pathlabs Share Price near the upper end on valuation while keeping returns strong.
About Dr. Lal Pathlabs
Dr. Lal Pathlabs Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company is known for diagnostic and related healthcare services, and Dr. Lal Pathlabs Share Price often reflects how the market values that business model against sector peers. The company’s market capitalisation of Rs 33,679.7 crore shows that it is a meaningful listed participant in the healthcare space, while its valuation and return ratios help frame investor discussion around Dr. Lal Pathlabs Stock News and Dr. Lal Pathlabs Stock Performance.
For readers following Dr. Lal Pathlabs Share Price Today, the business profile matters because earnings quality, book value, EPS, ROE, ROCE and dividend yield all feed into how the stock is assessed. Dr. Lal Pathlabs Share Price also sits within a sector where comparison with peers such as Apollo Hospitals, Max Healthcare, Fortis Healthcare, Aster DM Healthcare and MANIPAL HEALTH ENTERPRI L is standard practice. In Univest analysis, that makes the stock a regular name in Healthcare share price news and fundamental analysis discussions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Dr. Lal Pathlabs Share Price rising today?
Ans. Dr. Lal Pathlabs Share Price is rising today because the stock is up 2.2% to Rs 2,014.15. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Dr. Lal Pathlabs Share Price today?
Ans. Dr. Lal Pathlabs Share Price today is Rs 2,014.15. It is trading above the previous close of Rs 1,970.7, which makes the intraday move an important part of Dr. Lal Pathlabs Stock News.
How much did Dr. Lal Pathlabs Share Price gain today?
Ans. Dr. Lal Pathlabs Share Price gained Rs 43.45, which is a 2.2% rise from the previous close. The move also kept the stock near its day high of Rs 2,015.6.
What is Dr. Lal Pathlabs market cap?
Ans. Dr. Lal Pathlabs has a market capitalisation of Rs 33,679.7 crore. That places Dr. Lal Pathlabs Share Price well above the industry median market cap in the same industry benchmark set.
Is Dr. Lal Pathlabs Share Price expensive on valuation?
Ans. Dr. Lal Pathlabs Share Price trades at a P/E Ratio of 61.04 and a P/B Ratio of 12.66. Those levels are above the industry median and suggest a premium valuation profile.
How do Dr. Lal Pathlabs ROE and ROCE compare with the sector?
Ans. Dr. Lal Pathlabs shows ROE of 22.37% and ROCE of 29.56%, both above the sector medians of 13.01% and 15.84%. That supports the fundamental context behind Dr. Lal Pathlabs Share Price.
How does Dr. Lal Pathlabs compare with healthcare peers?
Ans. Dr. Lal Pathlabs Share Price compares well on ROCE and ROE versus several listed peers. Its valuation is also close to Max Healthcare on P/E Ratio while remaining above Fortis and Apollo on P/B Ratio.
What should investors monitor in Dr. Lal Pathlabs Share Price next?
Ans. Investors tracking Dr. Lal Pathlabs Share Price should watch the next price move, the company’s valuation ratios and any fresh company news. The current session’s rise is real, but the catalyst remains unconfirmed.
Track Dr. Lal Pathlabs Share Price on Univest
Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Dr. Lal Pathlabs Share Price on Univest for live updates on price action, valuation ratios, market capitalisation, 52-week levels and company context. Dr. Lal Pathlabs Share Price Today, Dr. Lal Pathlabs Stock News and Dr. Lal Pathlabs Share Price Update are covered in one place for quick comparison with sector peers and healthcare market trends.
